Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The University of Ottawa Heart Institute Research Corporation (UOHIRC) is the research and innovation arm of the University of Ottawa Heart Institute, Canada's premier cardiovascular center. The corporation oversees a vast research enterprise that integrates basic science, clinical research, and population health to advance the prevention and treatment of heart disease. UOHIRC is globally recognized for its leadership in cardiovascular imaging, particularly Positron Emission Tomography (PET), and its pioneering work in cardiac genetics and regenerative medicine. It manages numerous multi-center clinical trials and collaborates extensively with global pharmaceutical and medical device companies. The institute's mission is to translate laboratory discoveries into bedside treatments, significantly impacting cardiovascular care standards worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ottawa Heart Institute Research Corp..